Indication
Breast Cancer Stage I
8 clinical trials
12 products
Clinical trial
A Phase I Open-label Dose Escalation Trial of FWD1802 as Monotherapy and in Combination With Palbociclib in Patients With ER+/HER2- Unresectable Locally Advanced or Metastatic Breast CancerStatus: Recruiting, Estimated PCD: 2025-11-01
Product
FWD1802Product
palbocilibClinical trial
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast CancerStatus: Recruiting, Estimated PCD: 2026-07-01
Product
Capecitabine，PyrotinibClinical trial
A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast CancerStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
DC1 VaccineProduct
WOKVACClinical trial
ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence After Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection With and Without Axillary Reverse MappingStatus: Active (not recruiting), Estimated PCD: 2025-11-26
Product
Isosulfan BlueClinical trial
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Women With Early Breast Cancer; A Pragmatic Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2028-04-18
Product
DuloxetineProduct
FurosemideClinical trial
A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyStatus: Not yet recruiting, Estimated PCD: 2027-02-01
Product
Tart Cherry JuiceClinical trial
A Randomized Phase II Double-Blinded Study of The Efficacy of Oleogel-S10 (AP101) Gel for the Treatment of Grade 2/3 Radiation Dermatitis in Breast Cancer PatientsStatus: Recruiting, Estimated PCD: 2026-12-15
Product
Triamcinolone AcetonideProduct
Oleogel-S10Clinical trial
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating LymphocytesStatus: Not yet recruiting, Estimated PCD: 2032-09-15
Product
Adjuvant chemotherapy